Cargando…

Stem cell-dependent therapies : mesenchymal stem cells in chronic inflammatory disorders /

This book investigates the current state of the MSC-dependent therapy of chronic inflammatory disorders and autoimmune diseases. Among the covered topics are GvHD, chronic kidney, liver and lung disease, ischemic heart and inflammatory bowel disease, diabetes, osteoarthritis, various rheumatic and n...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Gross, Gerhard, 1949- (Editor ), Häupl, Thomas (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin : De Gruyter, [2013]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn872701330
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |n|||||||||
008 140204s2013 gw ob 001 0 eng d
040 |a CNSPO  |b eng  |e pn  |c CNSPO  |d OCLCO  |d YDXCP  |d N$T  |d DEBSZ  |d EBLCP  |d E7B  |d IDEBK  |d OCLCQ  |d OCLCO  |d OCLCQ  |d D6H  |d OCLCO  |d OCLCA  |d AGLDB  |d OCLCQ  |d DEGRU  |d DEBBG  |d UIU  |d CUY  |d COCUF  |d LOA  |d OCLCQ  |d MERUC  |d OCLCO  |d K6U  |d ICG  |d MOZ  |d STF  |d OCLCF  |d ZCU  |d OCLCO  |d WRM  |d VNS  |d OCLCO  |d OCL  |d VTS  |d OCLCO  |d OCLCQ  |d VT2  |d REC  |d U3W  |d UAB  |d WYU  |d OCLCO  |d OCLCA  |d OCLCQ  |d OCLCA  |d S9I  |d LVT  |d OCLCO  |d DKC  |d OCLCO  |d OCLCQ  |d LEAUB  |d UKAHL  |d UX1  |d UWK  |d ADU  |d OCLCA  |d OCLCQ  |d OCLCA  |d UKCRE  |d AJS  |d OCLCO  |d OCLCQ 
019 |a 862939080  |a 960883252  |a 965970727  |a 971999142  |a 978388748  |a 978908005  |a 979750441  |a 992858847  |a 1013939086  |a 1029483728  |a 1029820630  |a 1030819904  |a 1030838220  |a 1030904140  |a 1032683215  |a 1035648919  |a 1037982165  |a 1038692463  |a 1041976955  |a 1044945447  |a 1046613280  |a 1047011520  |a 1048336065  |a 1059051005  |a 1066440502  |a 1076656406  |a 1081118512  |a 1086448425  |a 1112818945  |a 1119020005  |a 1119089645  |a 1153535457  |a 1154240279  |a 1157970906  |a 1158912217  |a 1161546011  |a 1178725106  |a 1228541033 
020 |a 3110298309  |q (electronic bk.) 
020 |a 9783110298307  |q (electronic bk.) 
020 |z 9783110298260 
020 |z 3110298260 
024 7 |a 10.1515/9783110298307  |2 doi 
029 1 |a AU@  |b 000062433555 
029 1 |a DEBBG  |b BV043034369 
029 1 |a DEBSZ  |b 423654519 
029 1 |a GBVCP  |b 813953928 
035 |a (OCoLC)872701330  |z (OCoLC)862939080  |z (OCoLC)960883252  |z (OCoLC)965970727  |z (OCoLC)971999142  |z (OCoLC)978388748  |z (OCoLC)978908005  |z (OCoLC)979750441  |z (OCoLC)992858847  |z (OCoLC)1013939086  |z (OCoLC)1029483728  |z (OCoLC)1029820630  |z (OCoLC)1030819904  |z (OCoLC)1030838220  |z (OCoLC)1030904140  |z (OCoLC)1032683215  |z (OCoLC)1035648919  |z (OCoLC)1037982165  |z (OCoLC)1038692463  |z (OCoLC)1041976955  |z (OCoLC)1044945447  |z (OCoLC)1046613280  |z (OCoLC)1047011520  |z (OCoLC)1048336065  |z (OCoLC)1059051005  |z (OCoLC)1066440502  |z (OCoLC)1076656406  |z (OCoLC)1081118512  |z (OCoLC)1086448425  |z (OCoLC)1112818945  |z (OCoLC)1119020005  |z (OCoLC)1119089645  |z (OCoLC)1153535457  |z (OCoLC)1154240279  |z (OCoLC)1157970906  |z (OCoLC)1158912217  |z (OCoLC)1161546011  |z (OCoLC)1178725106  |z (OCoLC)1228541033 
037 |n Title subscribed to via ProQuest Academic Complete 
050 4 |a RB131  |b .S73 2013 
060 4 |a 2014 A-712 
060 4 |a QU 325 
072 7 |a QR  |2 lcco 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616/.0473  |2 23 
049 |a UAMI 
245 0 0 |a Stem cell-dependent therapies :  |b mesenchymal stem cells in chronic inflammatory disorders /  |c edited by Gerhard Gross and Thomas Häupl. 
264 1 |a Berlin :  |b De Gruyter,  |c [2013] 
300 |a 1 online resource (xviii, 408 pages .) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file 
347 |b PDF 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a Preface; Contributing authors; 1 Mesenchymal stem cells in the context of stem cell biology; 1.1 Introduction -- Definitions; 1.2 Embryonic and adult tissue stem cells; 1.3 Adult tissue stem cells and progenitors; 1.4 Adult stem cells and tissue homeostasis; 1.5 Adult stem cell niches; 1.6 Commitment and differentiation; 1.7 The case for bone marrow MSCs; 1.8 Clinical prospects; 1.9 Concluding remark; References; 2 Are mesenchymal stem cells immune privileged?; 2.1 Introduction -- Definition of mesenchymal stem cells (MSCs); 2.2 The immunosuppressive effect of MSCs on immune cells. 
505 8 |a 2.3 The potential clinical benefits of MSCs as immunosuppressants2.4 The mechanisms of immunosuppression by MSCs; 2.5 The mechanisms of immunosuppression by human MSCs; 2.6 Immunosuppression by murine MSCs and the species difference underlying the mechanisms of immunosuppression by MSCs; 2.7 Immunosuppression mediated by fibroblasts; 2.8 The mechanisms of the immunosuppressive effect of MSCs are shared with other nonstromal cells; 2.9 How long can MSCs survive in vivo?; 2.10 Conclusion and discussion; References; 3 Mesenchymal stem cell therapies for autoimmune diseases; 3.1 Introduction. 
505 8 |a 3.2 Autoimmune disease3.3 Mesenchymal stem cells (MSCs); 3.3.1 Animal models; 3.4 Results of MSCs clinical trials; 3.5 Safety of MSCs; 3.6 Conclusion; References; 4 Mesenchymal stem cells in osteoarthritis and rheumatic disease; 4.1 Introduction -- Rheumatic diseases; 4.2 Rheumatoid arthritis (RA); 4.3 Osteoarthritis (OA); 4.4 MSCs in healthy and rheumatic joint tissues; 4.5 Application of MSCs in rheumatic diseases; 4.6 MSCs application in animals; 4.7 Clinical studies in humans; 4.8 Risks and benefits of MSCs treatments in rheumatic diseases; References. 
505 8 |a 5 Mesenchymal stem cells in enthesis formation and repair5.1 Introduction; 5.2 Structure of the tendon-to-bone junction; 5.3 Enthesis resident T cells are involved in enthesopathies provoking inflammation and bone remodeling; 5.4 Biomaterials and growth factor-dependent regeneration of tendon-to-bone junctions; 5.5 Biomechanical stimulation for enthesis repair; 5.6 Mesenchymal stem cells (MSCs); 5.7 Stem cell-dependent approaches for repair of osteotendinous junctions; 5.8 Stem cell-dependent delivery of growth factors; 5.9 Stem cell-dependent delivery of tenogenic transcription factors. 
505 8 |a 5.10 Stem cell-dependent delivery of matrix metalloproteinases5.11 Trophic activities of MSCs in enthesis repair; 5.12 Outlook; Acknowledgment; References; 6 Mesenchymal stem cells for clinical/therapeutic interventions of graft-versus-host disease; 6.1 Clinical graft-versus-host disease; 6.2 Chronic graft-versus-host disease; 6.3 Rationale to use mesenchymal stromal cells for treatment of GvHD; 6.4 Experience of MSCs in clinical acute graft-versus-host disease. 
520 |a This book investigates the current state of the MSC-dependent therapy of chronic inflammatory disorders and autoimmune diseases. Among the covered topics are GvHD, chronic kidney, liver and lung disease, ischemic heart and inflammatory bowel disease, diabetes, osteoarthritis, various rheumatic and neurological disorders, tumors and solid organ transplantations. 
546 |a In English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Mesenchymal stem cells  |x Transplantation. 
650 0 |a Chronic diseases  |x Treatment. 
650 0 |a Inflammation  |x Immunological aspects. 
650 0 |a Inflammation  |x Treatment. 
650 0 |a Mesenchymal Stromal Cells. 
650 1 2 |a Mesenchymal Stem Cell Transplantation 
650 2 2 |a Chronic Disease  |x therapy 
650 2 2 |a Inflammation  |x immunology 
650 2 2 |a Inflammation  |x therapy 
650 2 2 |a Mesenchymal Stem Cells  |x immunology 
650 6 |a Cellules souches mésenchymateuses  |x Greffe. 
650 6 |a Maladies chroniques  |x Traitement. 
650 6 |a Inflammation (Pathologie)  |x Immunologie. 
650 6 |a Inflammation (Pathologie)  |x Traitement. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Chronic diseases  |x Treatment.  |2 fast  |0 (OCoLC)fst00860092 
650 7 |a Inflammation  |x Immunological aspects.  |2 fast  |0 (OCoLC)fst00972435 
700 1 |a Gross, Gerhard,  |d 1949-  |e editor. 
700 1 |a Häupl, Thomas,  |e editor. 
776 0 8 |i Print version:  |z 9783110298260  |z 3110298260  |w (DLC) 2013020145 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=661713  |z Texto completo 
936 |a BATCHLOAD 
938 |a Askews and Holts Library Services  |b ASKH  |n AH25313765 
938 |a De Gruyter  |b DEGR  |n 9783110298307 
938 |a EBL - Ebook Library  |b EBLB  |n EBL1113320 
938 |a ebrary  |b EBRY  |n ebr10811257 
938 |a EBSCOhost  |b EBSC  |n 661713 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis24682986 
938 |a YBP Library Services  |b YANK  |n 10817934 
994 |a 92  |b IZTAP